Journal for ImmunoTherapy of Cancer (Jun 2022)
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
- David P Carbone,
- Jair Bar,
- Alona Zer,
- Yuval Shaked,
- Michal Harel,
- Coren Lahav,
- Eyal Jacob,
- Ofer Sharon,
- Nili Dahan,
- Itamar Sela,
- Yehonatan Elon,
- Galit Yahalom,
- Iris Kamer,
- Adam P Dicker,
- Shani Raveh Shoval
Affiliations
- David P Carbone
- Aff4 grid.261331.40000000122857943Department of Medicine, James Cancer CenterThe Ohio State University Columbus OH USA
- Jair Bar
- 2 Thoracic Oncology Unit, Institute of Oncology, Tel HaShomer Hospital, Tel Hashomer, Israel
- Alona Zer
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Yuval Shaked
- Rappaport Faculty of Medicine, Rappaport Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, Israel
- Michal Harel
- OncoHost LTD, Binyamina, Israel
- Coren Lahav
- 1Oncohost LTD, Binyamina, Israel
- Eyal Jacob
- OncoHost LTD, Binyamina, Israel
- Ofer Sharon
- 1Oncohost LTD, Binyamina, Israel
- Nili Dahan
- OncoHost LTD, Binyamina, Israel
- Itamar Sela
- 1Oncohost LTD, Binyamina, Israel
- Yehonatan Elon
- 1Oncohost LTD, Binyamina, Israel
- Galit Yahalom
- 1Oncohost LTD, Binyamina, Israel
- Iris Kamer
- 2Chaim Sheba Medical Center, Ramat Gan, Israel
- Adam P Dicker
- Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
- Shani Raveh Shoval
- OncoHost Ltd, Binyamina, Israel
- DOI
- https://doi.org/10.1136/jitc-2022-004582
- Journal volume & issue
-
Vol. 10,
no. 6
Abstract
No abstracts available.
